NCT05826249View on ClinicalTrials.gov

Safety and Pharmacokinetics of SIM0417 Combined With Ritonavir in Healthy Elderly Subjects

PHASE1UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 7, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

November 30, 2023

Conditions
Elder
Interventions
DRUG

SIM0417/Ritonavir

Single oral dose of 750 mg SIM0417 coadministered with 100 mg ritonavir.

Trial Locations (1)

250014

RECRUITING

Shandong First Medical University, Jinan

Sponsors
All Listed Sponsors
lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY

NCT05826249 - Safety and Pharmacokinetics of SIM0417 Combined With Ritonavir in Healthy Elderly Subjects | Biotech Hunter | Biotech Hunter